Company Profile
- Stock Code
- QURE
- ISIN Code
- NL0010696654
- Currency
- US Dollar (USD)
- IPO Date
- 2007-06-20

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for th...